RTW Investments’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

RTW Investments’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-490,000	Closed	-$3.34M	–	105
2022 Q2	$3.34M	Hold	490,000	–	–	0.09%	83
2022 Q1	$3.9M	Hold	490,000	–	–	0.08%	82
2021 Q4	$2.74M	Hold	490,000	–	–	0.04%	105
2021 Q3	$3.77M	Hold	490,000	–	–	0.06%	101
2021 Q2	$5.03M	Hold	490,000	–	–	0.08%	89
2021 Q1	$5.15M	Hold	490,000	–	–	0.08%	91
2020 Q4	$6.82M	Hold	490,000	–	–	0.11%	79
2020 Q3	$7.05M	Buy	+490,000	New	+$6.68M	0.17%	71

Other funds holding PNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RTW Investments's PNT Position: Q3 2022 in Review

RTW Investments sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2022, closing a stake of 490,000 shares — an estimated $3.34M sold.

RTW Investments first reported a position in PNT in Q3 2020 and held it in 8 quarters. The position peaked at $7.05M in Q3 2020. 106 funds tracked by Wall St. Rank hold PNT as of Q3 2022.

RTW Investments reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
RTW Investments sold 490,000 POINT Biopharma Global Inc. Common Stock shares in Q3 2022, an estimated $3.34M.
RTW Investments first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 8 quarters.
RTW Investments's POINT Biopharma Global Inc. Common Stock position peaked at $7.05M in Q3 2020.
106 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.